TY - JOUR T1 - Maternal cigarette smoking and cleft lip and palate: A systematic review and meta-analysis JF - medRxiv DO - 10.1101/2021.06.10.21258688 SP - 2021.06.10.21258688 AU - Matthew Fell AU - Kyle Dack AU - Shaheel Chummun AU - Jonathan Sandy AU - Yvonne Wren AU - Sarah Lewis Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/14/2021.06.10.21258688.abstract N2 - Objectives A systematic review and meta-analysis to determine the association between active maternal smoking and cleft lip and palate etiology.Data Sources Medline, Embase, Web of Science and the Cochrane database from inception to November 2020.Study selection Observational studies of cigarette smoking habits in pregnant women. Outcomes included cleft lip and/or palate, cleft lip ± palate and cleft palate only.Data analysis Publication bias analyses were performed and the Newcastle Ottawa scales were used to assess study quality. Fixed or random effect models were used in the meta-analysis, dependent on risk of statistical heterogeneity.Results Forty-five studies were eligible for inclusion of which 11 were cohort and 34 were case-control studies. Sixteen studies were of sufficient standard for inclusion in the meta-analysis. The summary odds ratio for the association between smoking and cleft lip and/or palate was 1.42 (95%CI 1.27 to 1.59) with a population attributable fraction of 4% (95%CI 3% - 5%). There was limited evidence to show a dose-response effect of smoking.Conclusions This review reports a moderate association between maternal smoking and orofacial cleft but the overall quality of the conventional observational studies included was poor. There is a need for high quality and novel research strategies to further define the role of smoking in the etiology of cleft lip and palate.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMF is supported by the VTCT Foundation for a research fellowship with the CleftCollective at the University of Bristol KD is supported by a PhD studentship from the MRC Integrative Epidemiology Unit at the University of Bristol (faculty matched place for MRC and Peter and Jean James Scholarship) SL is supported by a project grant from the Medical Research Council (MR/T002093/1Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval rehired for this systematic review of secondary dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSecondary data published in the public domain used for this systematic review ER -